Study to Estimate the Degree of Metabolic Dysfunction Associated with Fatty Liver Disease through Continuous Glucose Monitoring

Study to Estimate the Degree of Metabolic Dysfunction Associated with Fatty Liver Disease through Continuous Glucose Monitoring - Study to estimate Metabolic Dysfunction Associated with Fatty Liver Disease through Continuous Glucose Monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053360

Enrollment

Registered

2024-03-01

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic dysfunction associated fatty liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have consented to the placebo-controlled double-blind randomized comparative trial (Number: C230011) investigating the improvement of fatty liver through brown rice supplementation targeting individuals with metabolic dysfunction-associated fatty liver disease (MAFLD). 2. having a will to attend this study

Exclusion criteria

Exclusion criteria: 1. Patients with severe skin disorders on the upper arm, the site of CGM attachment. 2. Patients inappropriate for this study by the researchers.

Design outcomes

Primary

Measure	Time frame
The relationship between CAP values, liver fat content measured by FibroScan and AC_Mean	—

Countries

Japan

Contacts

Public ContactTomoko Yamada

Kobe University Graduate School of Medicine Division of Diabetes and Endocrinology Department of Internal Medicine

yamada@med.kobe-u.ac.jp0783825862

Outcome results